Prognostic importance of preoperative anti-PF4/heparin antibodies in patients undergoing cardiac surgery
- 1 January 2012
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 107 (01) , 8-14
Abstract
Schattauer GmbH - Verlag für Medizin und Naturwissenschaften ist ein renommierter Herausgeber von Fachbüchern, -zeitschriften und -software. Besuchen Sie unser Internetangebot mit Onlinezugang zu unseren ZeitschriftenartikelnKeywords
This publication has 18 references indexed in Scilit:
- Incidence and clinical relevance of anti–platelet factor 4/heparin antibodies before cardiac surgeryAmerican Heart Journal, 2010
- Heparin-induced thrombocytopenia (HIT): Clinical and economic outcomesThrombosis and Haemostasis, 2008
- Beyond the platelet count: Heparin antibodies as independent risk predictorsAmerican Heart Journal, 2007
- Positive Heparin-Platelet Factor 4 Antibody Complex and Cardiac Surgical OutcomesThe Annals of Thoracic Surgery, 2007
- Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongationThrombosis and Haemostasis, 2005
- Prevalence of Heparin-Associated Antibodies Without Thrombosis in Patients Undergoing Cardiopulmonary Bypass SurgeryCirculation, 1997
- Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexesJournal of Laboratory and Clinical Medicine, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.Journal of Clinical Investigation, 1994